PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
SMMT vs. PHM
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


SMMTPHM
YTD Return695.40%25.47%
1Y Return1,028.26%58.17%
3Y Return (Ann)56.94%37.46%
5Y Return (Ann)68.74%28.27%
Sharpe Ratio3.321.85
Sortino Ratio5.982.53
Omega Ratio1.791.32
Calmar Ratio11.183.92
Martin Ratio47.059.92
Ulcer Index21.03%5.80%
Daily Std Dev298.54%31.17%
Max Drawdown-95.75%-92.40%
Current Drawdown-34.98%-13.53%

Fundamentals


SMMTPHM
Market Cap$15.31B$26.43B
EPS-$0.23$13.55
PEG Ratio0.000.34
Total Revenue (TTM)-$235.00K$17.32B
Gross Profit (TTM)-$907.00K$5.11B
EBITDA (TTM)-$174.22M$3.78B

Correlation

-0.50.00.51.00.1

The correlation between SMMT and PHM is 0.12, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

SMMT vs. PHM - Performance Comparison

In the year-to-date period, SMMT achieves a 695.40% return, which is significantly higher than PHM's 25.47% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


0.00%100.00%200.00%300.00%400.00%500.00%600.00%JuneJulyAugustSeptemberOctoberNovember
343.08%
11.28%
SMMT
PHM

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

SMMT vs. PHM - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Summit Therapeutics Inc. (SMMT) and PulteGroup, Inc. (PHM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


SMMT
Sharpe ratio
The chart of Sharpe ratio for SMMT, currently valued at 3.32, compared to the broader market-4.00-2.000.002.004.003.32
Sortino ratio
The chart of Sortino ratio for SMMT, currently valued at 5.98, compared to the broader market-4.00-2.000.002.004.006.005.98
Omega ratio
The chart of Omega ratio for SMMT, currently valued at 1.79, compared to the broader market0.501.001.502.001.79
Calmar ratio
The chart of Calmar ratio for SMMT, currently valued at 11.18, compared to the broader market0.002.004.006.0011.18
Martin ratio
The chart of Martin ratio for SMMT, currently valued at 47.05, compared to the broader market0.0010.0020.0030.0047.05
PHM
Sharpe ratio
The chart of Sharpe ratio for PHM, currently valued at 1.85, compared to the broader market-4.00-2.000.002.004.001.85
Sortino ratio
The chart of Sortino ratio for PHM, currently valued at 2.53, compared to the broader market-4.00-2.000.002.004.006.002.53
Omega ratio
The chart of Omega ratio for PHM, currently valued at 1.32, compared to the broader market0.501.001.502.001.32
Calmar ratio
The chart of Calmar ratio for PHM, currently valued at 3.92, compared to the broader market0.002.004.006.003.92
Martin ratio
The chart of Martin ratio for PHM, currently valued at 9.92, compared to the broader market0.0010.0020.0030.009.92

SMMT vs. PHM - Sharpe Ratio Comparison

The current SMMT Sharpe Ratio is 3.32, which is higher than the PHM Sharpe Ratio of 1.85. The chart below compares the historical Sharpe Ratios of SMMT and PHM, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio1.002.003.004.005.00JuneJulyAugustSeptemberOctoberNovember
3.32
1.85
SMMT
PHM

Dividends

SMMT vs. PHM - Dividend Comparison

SMMT has not paid dividends to shareholders, while PHM's dividend yield for the trailing twelve months is around 0.62%.


TTM20232022202120202019201820172016201520142013
SMMT
Summit Therapeutics Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
PHM
PulteGroup, Inc.
0.62%0.66%1.34%1.00%1.16%1.16%1.46%1.08%1.96%1.85%1.07%0.74%

Drawdowns

SMMT vs. PHM - Drawdown Comparison

The maximum SMMT drawdown since its inception was -95.75%, roughly equal to the maximum PHM drawdown of -92.40%. Use the drawdown chart below to compare losses from any high point for SMMT and PHM. For additional features, visit the drawdowns tool.


-80.00%-60.00%-40.00%-20.00%0.00%JuneJulyAugustSeptemberOctoberNovember
-34.98%
-13.53%
SMMT
PHM

Volatility

SMMT vs. PHM - Volatility Comparison

Summit Therapeutics Inc. (SMMT) has a higher volatility of 25.67% compared to PulteGroup, Inc. (PHM) at 11.68%. This indicates that SMMT's price experiences larger fluctuations and is considered to be riskier than PHM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%50.00%100.00%150.00%JuneJulyAugustSeptemberOctoberNovember
25.67%
11.68%
SMMT
PHM

Financials

SMMT vs. PHM - Financials Comparison

This section allows you to compare key financial metrics between Summit Therapeutics Inc. and PulteGroup, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Values in USD except per share items